S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ARWR Arrowhead Pharmaceuticals Inc

18.28

-0.43 (-2.30%)

After Hours

Last Updated: 15:25:00

Delayed by 15 minutes

Form 5 - Annual statement of changes in beneficial ownership of securities

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Arrowhead Pharmaceuticals Charts.

Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Arrowhead Pharmaceuticals Charts.

Arrowhead Pharmaceuticals Inc News

Form 5 - Annual statement of changes in beneficial ownership of securities
Friday 15 November 2024 (6 days ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 6 May 2024 (7 months ago) • Edgar (US Regulatory)

Turnstone Biologics Appoints William Waddill to its Board of Directors
Tuesday 16 April 2024 (7 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (8 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 6 March 2024 (9 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 27 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 6 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 6 February 2024 (9 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 2 February 2024 (10 months ago) • Edgar (US Regulatory)

More Arrowhead Pharmaceuticals Inc News Articles

Align Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions